Other languages Surmodics, Inc.

Equities

SRDX

US8688731004

Real-time Estimate Cboe BZX Other stock markets 10:25:52 2024-06-06 am EDT			5-day change	1st Jan Change
42.02 ^USD	+0.06%		-0.24%	+15.54%

May. 30	Barrington Research Downgrades SurModics to Market Perform From Outperform	MT
May. 29	Needham Downgrades SurModics to Hold From Buy	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Lean Lower Premarket Wednesday	May. 29
Sector Update: Health Care	May. 29
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday After Fed Speaker's Hawkish Comments	May. 29
Top Premarket Gainers	May. 29
SurModics Agrees to be Acquired by Private Equity Firm GTCR for $627 Million; Shares Rise Pre-Bell	May. 29
Top Midday Gainers	May. 01
Surmodics, Inc. Revises Earnings Guidance for the Fiscal Year 2024	May. 01
Surmodics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 01
Surmodics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 01
Surmodics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 01
Surmodics, Inc. Announces Successful Early Clinical Use of its Pounce LP Thrombectomy System	Jan. 22
Surmodics, Inc. Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium	Nov. 16
Surmodics, Inc. Announces 24-Month Data from the Swing Trial Presented At VEITHsymposium	Nov. 16
Surmodics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Nov. 08
Surmodics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Nov. 08
Surmodics, Inc. Provides Earnings Guidance for the Year 2024	Nov. 08
Surmodics, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Nov. 08
Surmodics, Inc. Announces Swing Trial 24-Month Data to Be Presented At Veith Symposium on November 15	Nov. 07
Surmodics, Inc. Announces Launch of Preside Medical Device Coating Technology, Providing Lubricity and Durability to a Broader Range of Complex Device Applications	23-10-31
Surmodics, Inc. Revises Earnings Guidance for the Fiscal Year Ending September 30, 2023	23-08-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Surmodics, Inc.

Equities

SRDX

US8688731004

Other languages

Filters